A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Almotriptan
Xylazine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Xylazine.
Almotriptan
Medetomidine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Medetomidine.
Almotriptan
Doramectin
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Doramectin.
Almotriptan
Azaperone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Azaperone.
Almotriptan
Alfaxalone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Alfaxalone.
Almotriptan
Pyrantel
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Pyrantel.
Almotriptan
Opium
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Opium.
Almotriptan
Oxaprotiline
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Oxaprotiline.
Almotriptan
Ramosetron
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Ramosetron.
Almotriptan
Tianeptine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Tianeptine.
Almotriptan
Pipamperone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Pipamperone.
Almotriptan
Caroxazone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Caroxazone.
Almotriptan
Safrazine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Safrazine.
Almotriptan
Pivhydrazine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Pivhydrazine.
Almotriptan
Phenoxypropazine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Phenoxypropazine.
Almotriptan
Pheniprazine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Pheniprazine.
Almotriptan
Octamoxin
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Octamoxin.
Almotriptan
Mebanazine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Mebanazine.
Almotriptan
Iproclozide
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Iproclozide.
Almotriptan
Benmoxin
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Benmoxin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3